ALLEGRA tablets Seasonal Allergic Rhinitis and Chronic Idiopathic Urticaria
Adults and Children 12 Years and Older. The recommended dose of
ALLEGRA tablets is 60 mg twice daily or 180 mg once daily with water. A dose of
60 mg once daily is recommended as the starting dose in patients with decreased
renal function.
Children 6 to 11 Years. The recommended dose of ALLEGRA tablets
is 30 mg twice daily with water. A dose of 30 mg once daily is recommended as
the starting dose in pediatric patients with decreased renal function.
ALLEGRA ODT Seasonal Allergic Rhinitis and Chronic Idiopathic Urticaria
Children 6 to 11 Years. ALLEGRA ODT is intended for use only in
children 6 to 11 years of age. The recommended dose of ALLEGRA ODT is 30 mg
twice daily. A dose of 30 mg once daily is recommended as the starting dose in
pediatric patients with decreased renal function.
ALLEGRA ODT is designed to disintegrate on the tongue, followed by swallowing
with or without water. ALLEGRA ODT should be taken on an empty stomach. ALLEGRA
ODT is not intended to be chewed.
ALLEGRA ODT should not be removed from the original blister package until the
time of administration.
ALLEGRA oral suspension
Seasonal Allergic Rhinitis
Children 2 to 11 Years : The recommended dose of ALLEGRA oral
suspension is 30 mg twice daily. A dose of 30 mg (5 mL) once daily is
recommended as the starting dose in pediatric patients with decreased renal
function
Shake bottle well before each use.
Chronic Idiopathic Urticaria Children 6 Months to 11 years: The recommended dose of ALLEGRA
oral suspension is 30 mg (5 mL) twice daily for patients 2 to 11 years of age
and 15 mg (2.5 mL) twice daily for patients 6 months to less than 2 years of
age. For pediatric patients with decreased renal function, the recommended
starting doses of ALLEGRA oral suspension are 30 mg (5 mL) once daily for
patients 2 to 11 years of age and 15 mg (2.5 mL), once daily for patients 6
months to less than 2 years of age.
Shake bottle well, before each use.
Renal Dosing
Renally Impaired.
In subjects with mild to moderate (creatinine clearance 41–80 mL/min)
and severe (creatinine clearance 11–40 mL/min) renal impairment, peak
plasma concentrations of fexofenadine were 87% and 111% greater,
respectively, and mean elimination half-lives were 59% and 72% longer,
respectively, than observed in healthy subjects.
Peak plasma concentrations in subjects on dialysis (creatinine clearance
10 mL/min) were 82%
greater and half-life was 31% longer than observed in healthy subjects.
Based on increases in bioavailability and half-life, a dose of 60 mg
once daily is recommended as the starting dose in adult patients with
decreased renal function.
For pediatric patients with decreased renal function, the recommended
starting dose of fexofenadine is 30 mg once daily for patients 2 to 11
years of age and 15 mg once daily for patients 6 months to less than 2
years of age.
Hemodialysis
Insufficient data
Disclaimer
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
CAREFULLY
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read
the disclaimer
Don't forget to check out the extensive health
section....